MK

Mithu Kumari

Active Director Director DIN 09295972
DIN 09295972 First appointment Aug 2021 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2021
Shareholding value •••• Premium profile

About Mithu Kumari

Data last updated:

Mithu Kumari is a Director at Medusion Life Science Private Limited (since 2021). The company operates in Chemicals. Medusion Life Science Private Limited reported revenue of ₹1.6 Lakh (FY 2023).

DIN 09295972
Primary Designation Director
Industry Chemicals
First Appointment 27 Aug 2021
Oldest Company Age 5 yrs
Largest company Medusion Life Science Private Limited · ₹1.6 Lakh (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Aug 20212021₹1.6 Lakh (FY 2023)Active

Board colleagues of Mithu Kumari

NameDINCompanyDesignation
Binay Kumar09295971Medusion Life Science Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medusion Life Science Private Limited
Premium access

Shareholding and investment profile for Mithu Kumari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mithu Kumari

Mithu Kumari currently holds 1 directorship: Medusion Life Science Private Limited (Director, since 27 Aug 2021, revenue ₹1.6 Lakh (FY 2023)).

Mithu Kumari was first appointed on 27 Aug 2021 as Director at Medusion Life Science Private Limited.

The current boards of Mithu Kumari's companies include Binay Kumar (Medusion Life Science Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available